Pfizer Files More Suits To Block Generic Toviaz
Pfizer Inc. launched a series of patent infringement suits Friday in Delaware federal court against Amneal Pharmaceuticals LLC, Impax Laboratories and other generic-drug manufacturers for seeking approval for their own versions...To view the full article, register now.
Already a subscriber? Click here to view full article